MX338338B - Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias. - Google Patents

Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.

Info

Publication number
MX338338B
MX338338B MX2008013258A MX2008013258A MX338338B MX 338338 B MX338338 B MX 338338B MX 2008013258 A MX2008013258 A MX 2008013258A MX 2008013258 A MX2008013258 A MX 2008013258A MX 338338 B MX338338 B MX 338338B
Authority
MX
Mexico
Prior art keywords
compositions
treatment
respiratory illness
methods useful
free
Prior art date
Application number
MX2008013258A
Other languages
English (en)
Other versions
MX2008013258A (es
Inventor
Jayant Eknath Khanolkar
Douglas William Gledhill
Kelly Lee Martin
Susan Elaine Criss
Niranjan Ramji
Elaine Rose Costeines
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38620207&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX338338(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2008013258A publication Critical patent/MX2008013258A/es
Publication of MX338338B publication Critical patent/MX338338B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen las composiciones que incluyen fenilefrina, sus formas libres y con adición de sal, y mezclas de éstas, solas, o en combinación con otros activos farmacéuticos. Las composiciones poseen un pH de aproximadamente 2 a aproximadamente 5 y están prácticamente libres de aldehídos. También se describen métodos para el tratamiento de enfermedades respiratorias por medo de la administración de una composición, que comprende fenilefrina, sus formas libres y con adición de sales, y mezclas de éstas solamente, o en combinación con otros activos farmacéuticos, en donde la composición posee un pH de aproximadamente 2 a aproximadamente y está prácticamente libre de aldehídos.
MX2008013258A 2006-04-21 2007-04-20 Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias. MX338338B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/408,299 US10022339B2 (en) 2006-04-21 2006-04-21 Compositions and methods useful for treatment of respiratory illness
PCT/IB2007/051469 WO2007122580A2 (en) 2006-04-21 2007-04-20 Compositions of phenylephrine useful for treatment of respiratory illness

Publications (2)

Publication Number Publication Date
MX2008013258A MX2008013258A (es) 2009-03-06
MX338338B true MX338338B (es) 2015-07-07

Family

ID=38620207

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008013258A MX338338B (es) 2006-04-21 2007-04-20 Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.

Country Status (11)

Country Link
US (7) US10022339B2 (es)
EP (2) EP2724720B1 (es)
JP (1) JP2009534371A (es)
CN (1) CN101495110B (es)
AU (1) AU2007242418B2 (es)
BR (1) BRPI0710485B8 (es)
CA (1) CA2650033C (es)
ES (1) ES2667331T3 (es)
MX (1) MX338338B (es)
PL (1) PL2724720T3 (es)
WO (1) WO2007122580A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine
WO2009140853A1 (en) * 2008-05-23 2009-11-26 The University Of Hong Kong Combination therapy for the treatment of influenza
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) * 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) * 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
EP2593094B1 (de) * 2010-07-12 2017-12-06 Sanofi-Aventis Deutschland GmbH Wässrige zusammensetzung enthaltend bromhexin
BR112015019347B1 (pt) 2013-02-13 2022-12-20 The Procter & Gamble Company Medicamento com sabor de anis
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015051264A1 (en) 2013-10-03 2015-04-09 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricatiing thereof
LT3069733T (lt) * 2013-11-13 2022-11-25 National Defense Education And Research Foundation Nauja acetaminofeno junginio sudėtis be šalutinio poveikio kepenims
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
EP3169315B1 (en) 2014-07-17 2020-06-24 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN105982897B (zh) * 2015-02-13 2021-01-01 北京韩美药品有限公司 液体制剂、其制备方法及应用
US11213480B1 (en) 2015-08-06 2022-01-04 Hikma Pharmaceuticals International Limited Phenylephrine hydrochloride ready-to-use solution
WO2018039420A1 (en) 2016-08-25 2018-03-01 Imprimis Pharmaceuticals, Inc. Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
CN108434097A (zh) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 一种稳定的含***普利啶口服溶液剂及其制备方法
CN109045003B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚拉明肾素口服液及其制备方法
CN109044968B (zh) * 2018-10-18 2020-12-01 云南大唐汉方制药股份有限公司 氨酚右美肾素口服液及其制备方法
CN109010341A (zh) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 一种含有氢溴酸右美沙芬的复方口服溶液及其制备方法
CN110279695B (zh) * 2019-08-07 2022-04-08 北京博智绿洲医药科技有限公司 一种治疗流涕、鼻塞等感冒症状的药物组合物及其制备方法和用途
CN110327339A (zh) * 2019-08-07 2019-10-15 北京博达绿洲医药科技研究有限公司 一种复方右美沙芬口服溶液及其制备方法和用途
CN112076183A (zh) * 2020-08-28 2020-12-15 北京博达绿洲医药科技研究有限公司 包含盐酸去氧肾上腺素液体组合物
WO2022060847A1 (en) * 2020-09-17 2022-03-24 Adulsa Therapeutics Corp. Methods of inhibiting diseases caused by respiratory viruses
AU2022201576A1 (en) * 2022-03-08 2023-09-28 Aft Pharmaceuticals Limited Medication

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB836747A (en) 1957-07-31 1960-06-09 Upjohn Co Improvements in or relating to steroidal compounds and compositions and the preparation thereof
GB895495A (en) 1960-01-20 1962-05-02 Boots Pure Drug Co Ltd Amino-acetamidoximes and their preparation
US3169092A (en) * 1963-09-26 1965-02-09 Richardson Merrell Inc Stabilization of amines by tartrazine and bisulfite
US3293045A (en) * 1963-10-18 1966-12-20 Pfizer & Co C Increasing the flavor strength of anethole, cinnamaldehyde and methyl salicylate with maltol
GB1121358A (en) 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US3480185A (en) * 1966-06-20 1969-11-25 Johnson & Johnson Charged effervescing agent and medicament dispensing metering valve-actuated aerosol container producing a dose of medicament and carbonation in water
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPH0780760B2 (ja) 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
DE3868793D1 (de) 1987-09-04 1992-04-09 Procter & Gamble Psyllium enthaltende fuellungszusammenstellungen.
DK0387933T3 (da) 1989-03-16 1993-12-06 Procter & Gamble Psylliumholdige, bagte småkagesammensætninger
JP3256997B2 (ja) 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
US5178025A (en) 1990-08-31 1993-01-12 Innovative Medical Engineering, Inc. Tiltable lift seat devices
US5196436A (en) 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
EP0662840A1 (en) * 1992-10-09 1995-07-19 The Procter & Gamble Company Pharmaceutical compositions and methods for treating cold symptoms
US5480674A (en) 1993-06-25 1996-01-02 Firmenich Incorporated Flavor composition for an oral electrolyte rehydration solution
JP3643604B2 (ja) 1993-09-17 2005-04-27 セイコーインスツル株式会社 内面研削盤における研削方法
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
JPH09286726A (ja) 1996-04-18 1997-11-04 Takeda Chem Ind Ltd 経口液剤
JPH09286723A (ja) 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤
JPH09286724A (ja) 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
US5660833A (en) * 1996-06-05 1997-08-26 Medenica; Rajko D. Anti-tussive composition
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
JPH10167988A (ja) 1996-10-09 1998-06-23 Takeda Chem Ind Ltd 経口液剤
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
ATE241341T1 (de) * 1997-09-10 2003-06-15 Takeda Chemical Industries Ltd Stabilisierte pharmazeutische zusammensetzung
CA2311530C (en) 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6287597B1 (en) * 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
PT1283043E (pt) 2000-05-17 2008-02-07 Senju Pharma Co Solução oftálmica
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
CA2423354C (en) * 2000-09-20 2009-12-15 Lee Shahinian Jr. Self-preserved nasal, inhalable, and topical ophthalmic preparations and medications
JP2002212107A (ja) 2001-01-22 2002-07-31 Taisho Pharmaceut Co Ltd 局所適用組成物
EP1411955A4 (en) 2001-07-31 2006-07-05 Wyeth Corp SUCRALOSE FORMULATIONS FOR COVERING UNANGEAN TASTE
US20030026826A1 (en) 2001-07-31 2003-02-06 Cherukuri Subraman Rao Sugar-free chewy products and protein-based chewy products and methods for making the same
US20040132827A1 (en) * 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US20030083354A1 (en) * 2001-10-26 2003-05-01 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
AU2002352974A1 (en) * 2001-11-29 2003-06-10 Emisphere Technologies, Inc. Formulations for oral administration of cromolyn sodium
US7101572B2 (en) 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
US20030170371A1 (en) 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
BR0307755A (pt) 2002-02-04 2004-12-07 Pharmacia Corp Tratamento de resfriados e tosse com uma combinação de um inibidor seletivo da ciclooxigenase-2 e um ingrediente ativo contra resfriados e tosse e composições dos mesmos
EP1559433A4 (en) 2002-10-22 2009-11-04 Dainippon Sumitomo Pharma Co STABILIZED COMPOSITION
US20050214349A1 (en) 2002-10-30 2005-09-29 Li Nie Extruded gluten based pet chew bodies
US20060193959A1 (en) 2002-10-30 2006-08-31 Li Nie Low calorie injection molded starch-based pet chew bodies
US20040259955A1 (en) 2002-11-08 2004-12-23 Boehringer Ingelheim International Gmbh New pharmaceutical compositions containing ambroxol and isopropamide iodide
DE10261061A1 (de) 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
JP2004217596A (ja) 2003-01-17 2004-08-05 Taisho Pharmaceut Co Ltd 点眼剤組成物
US20040162273A1 (en) 2003-01-23 2004-08-19 The Procter & Gamble Company Powder pharmaceutical compositions
JP2004300138A (ja) 2003-03-18 2004-10-28 Takeda Chem Ind Ltd 安定化された経口固形製剤
WO2004084637A1 (en) 2003-03-24 2004-10-07 Council Of Scientific And Industrial Research A high fibre biscuit composition and a process for preparing the same
JP4473539B2 (ja) 2003-08-12 2010-06-02 エスエス製薬株式会社 医薬組成物
US7118772B2 (en) 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
DE10358213A1 (de) 2003-12-12 2005-07-28 Clariant Gmbh Polyethylenglykol und dessen Herstellung
US20050266032A1 (en) 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20060188450A1 (en) * 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
DE102006030757A1 (de) 2005-07-18 2007-02-01 Carl Zeiss Smt Ag Polarisationsoptimiertes Beleuchtungssystem
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
US20070178123A1 (en) * 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
US8940796B2 (en) * 2006-02-21 2015-01-27 Wyeth Llc Phenylephrine liquid formulations
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070254027A1 (en) 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20080014275A1 (en) 2006-07-13 2008-01-17 Buehler Gail K Pharmaceutical suspensions and related methods
US20080014274A1 (en) 2006-07-14 2008-01-17 Wyeth Enhanced stability phenylephrine liquid compositions
US20080069874A1 (en) 2006-09-15 2008-03-20 Auriga Laboratories, Inc. Kits for Prevention and Treatment of Rhinitis
LU92526B1 (fr) 2013-02-04 2014-12-22 Aft Pharmaceuticals Ltd Medicament de combinaison comprenant de la phenylephrine et du paracetamol

Also Published As

Publication number Publication date
EP2724720A1 (en) 2014-04-30
CA2650033C (en) 2013-07-02
BRPI0710485B8 (pt) 2021-05-25
US20180360781A1 (en) 2018-12-20
BRPI0710485A8 (pt) 2018-01-02
US11077074B2 (en) 2021-08-03
WO2007122580A3 (en) 2009-03-19
CN101495110B (zh) 2013-02-20
AU2007242418B2 (en) 2013-04-11
CA2650033A1 (en) 2007-11-01
PL2724720T3 (pl) 2018-09-28
EP2724720B1 (en) 2018-02-21
US20210353562A1 (en) 2021-11-18
US10022339B2 (en) 2018-07-17
BRPI0710485A2 (pt) 2011-08-16
US10772848B2 (en) 2020-09-15
WO2007122580A2 (en) 2007-11-01
ES2667331T3 (es) 2018-05-10
JP2009534371A (ja) 2009-09-24
US20180338933A1 (en) 2018-11-29
EP2032129A2 (en) 2009-03-11
EP2032129B1 (en) 2014-01-29
US20180360778A1 (en) 2018-12-20
US11083697B2 (en) 2021-08-10
US20180360779A1 (en) 2018-12-20
AU2007242418A1 (en) 2007-11-01
US20070249566A1 (en) 2007-10-25
BRPI0710485B1 (pt) 2020-04-28
CN101495110A (zh) 2009-07-29
US20180360780A1 (en) 2018-12-20
MX2008013258A (es) 2009-03-06

Similar Documents

Publication Publication Date Title
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
MX2010014233A (es) Compuestos quimicos 251.
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
EA200870019A1 (ru) Лактамовые соединения и способы их применения
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
CL2007003635A1 (es) Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer.
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
WO2007112000A3 (en) Treatment of pain
TW200734334A (en) Treatment of substance abuse
TW200639159A (en) Treatment of pain
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
TNSN07419A1 (en) Methods for treating drug resistant cancer
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
CY1109743T1 (el) Παραγωγα των 2-βενζοϋλο-ιμιδαζοπυριδινων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
ATE507214T1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
TNSN08506A1 (en) Substituted carboxamides
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
NO20076405L (no) Anvendelse av 24-nor-UDCA
CL2008000982A1 (es) Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration